Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Dahu Health Industry Co's annualizedNet Income for the quarter that ended in Jun. 2026 was ¥79.3 Mil. Dahu Health Industry Co's average total tangible assets for the quarter that ended in Jun. 2026 was ¥1,587.5 Mil. Therefore, Dahu Health Industry Co's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 4.99%.
The historical rank and industry rank for Dahu Health Industry Co's Return-on-Tangible-Asset or its related term are showing as below:
SHSE:600257'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -9.55 Med: -0.09 Max: 1.53
Current: 1.53
During the past 13 years, Dahu Health Industry Co's highest Return-on-Tangible-Asset was 1.53%. The lowest was -9.55%. And the median was -0.09%.
SHSE:600257's Return-on-Tangible-Asset is ranked worse than 63.72% of 2001
companies
in the Consumer Packaged Goods industry
Industry Median: 3.54
vs SHSE:600257: 1.53
Dahu Health Industry Co (SHSE:600257) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Dahu Health Industry Co Return-on-Tangible-Asset Related Terms
Dahu Health Industry Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Dahu Health Industry Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dahu Health Industry Co Return-on-Tangible-Asset Chart
SHSE:600257 vs ADM, BG, TSN: Return-on-Tangible-Asset Comparison
For the Farm Products subindustry, Dahu Health Industry Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dahu Health Industry Co Return-on-Tangible-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dahu Health Industry Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Dahu Health Industry Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 4.99% mean?
Dahu Health Industry Co (SHSE:600257) has a Return-on-Tangible-Asset of 4.99% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Dahu Health Industry Co and its competitors. According to the industry distribution chart, Dahu Health Industry Co ranks #1275 out of 2001 companies in the Consumer Packaged Goods industry, placing it in the top 63.7%.
Is Dahu Health Industry Co's Return-on-Tangible-Asset too high?
Dahu Health Industry Co's current Return-on-Tangible-Asset is 4.99%. The Consumer Packaged Goods industry median Return-on-Tangible-Asset is 3.54. Dahu Health Industry Co's value of 4.99% is 41% above this industry median. Based on the distribution chart, Dahu Health Industry Co ranks #1275 out of 2001 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Dahu Health Industry Co has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dahu Health Industry Co's Return-on-Tangible-Asset compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Dahu Health Industry Co ranks #1275 out of 2001 companies for Return-on-Tangible-Asset. This places Dahu Health Industry Co in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.54. Dahu Health Industry Co's value of 4.99% is 41% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Consumer Packaged Goods company?
The median Return-on-Tangible-Asset among Consumer Packaged Goods companies is 3.54, based on 2,001 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dahu Health Industry Co's current Return-on-Tangible-Asset of 4.99% is 41% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Dahu Health Industry Co and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Asset is 3.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dahu Health Industry Co's current Return-on-Tangible-Asset is 4.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dahu Health Industry Co stock overvalued right now?
Based on GuruFocus' analysis, Dahu Health Industry Co (SHSE:600257) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.62, compared to a current price of ¥5.86 — trading 26.8% above its estimated fair value. The current Return-on-Tangible-Asset is 4.99% and 41% above the Consumer Packaged Goods industry median of 3.54. Dahu Health Industry Co's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Dahu Health Industry Co (SHSE:600257), the current Return-on-Tangible-Asset is 4.99% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dahu Health Industry Co (SHSE:600257) Overvalued in 2026?
Based on GuruFocus' analysis, Dahu Health Industry Co stock appears to be overvalued.
The current stock price of ¥5.86 is trading 26.8% above its estimated GF Value™ of ¥4.62.
GuruFocus considers Dahu Health Industry Co to be Modestly Overvalued.
Key valuation signals for SHSE:600257:
Return-on-Tangible-Asset: 4.99%
GF Value™: ¥4.62 vs. price of ¥5.86 (26.8% above fair value)
Industry Position: 41% above the Consumer Packaged Goods median (#1275 of 2001)
No single metric tells the full story. See the SHSE:600257 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dahu Health Industry Co Ltd engages in aquatic products and waterfowl breeding, processing, and comprehensive development, alongside foreign investment in proprietary Chinese medicine production and sales. Its operations include medical and food production and sales, nursing, hospital, elderly care, and health services. It also provides artificial intelligence-related technical consulting and system integration, and sells consumer robots.
49GF Score
Get the complete analysis for SHSE:600257
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600257 has been successfully added to your 
